AAPL   321.62 (-0.07%)
MSFT   183.27 (+0.24%)
FB   229.39 (-1.09%)
GOOGL   1,433.04 (-0.13%)
NVDA   351.57 (-0.19%)
CGC   16.28 (-1.21%)
MU   46.50 (+0.35%)
AMD   52.88 (-1.40%)
T   30.90 (-0.10%)
GILD   73.25 (-2.54%)
DIS   118.26 (-0.43%)
AAPL   321.62 (-0.07%)
MSFT   183.27 (+0.24%)
FB   229.39 (-1.09%)
GOOGL   1,433.04 (-0.13%)
NVDA   351.57 (-0.19%)
CGC   16.28 (-1.21%)
MU   46.50 (+0.35%)
AMD   52.88 (-1.40%)
T   30.90 (-0.10%)
GILD   73.25 (-2.54%)
DIS   118.26 (-0.43%)
AAPL   321.62 (-0.07%)
MSFT   183.27 (+0.24%)
FB   229.39 (-1.09%)
GOOGL   1,433.04 (-0.13%)
NVDA   351.57 (-0.19%)
CGC   16.28 (-1.21%)
MU   46.50 (+0.35%)
AMD   52.88 (-1.40%)
T   30.90 (-0.10%)
GILD   73.25 (-2.54%)
DIS   118.26 (-0.43%)
AAPL   321.62 (-0.07%)
MSFT   183.27 (+0.24%)
FB   229.39 (-1.09%)
GOOGL   1,433.04 (-0.13%)
NVDA   351.57 (-0.19%)
CGC   16.28 (-1.21%)
MU   46.50 (+0.35%)
AMD   52.88 (-1.40%)
T   30.90 (-0.10%)
GILD   73.25 (-2.54%)
DIS   118.26 (-0.43%)
Log in

NYSE:MDCM.D.C. Stock Price, Forecast & News

$34.48
+0.48 (+1.41 %)
(As of 06/2/2020 02:24 PM ET)
Add
Compare
Today's Range
$34.02
Now: $34.48
$34.73
50-Day Range
$23.26
MA: $28.23
$36.69
52-Week Range
$15.75
Now: $34.48
$48.99
Volume7,800 shs
Average Volume648,227 shs
Market Capitalization$2.17 billion
P/E Ratio9.50
Dividend Yield3.88%
Beta1.51
M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, Washington, Colorado, Utah, Virginia, Florida, Maryland, Pennsylvania, and New Jersey. Its financial services operations consist of originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.
Read More
M.D.C. logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.0Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.04 out of 5 stars


Industry, Sector and Symbol

Industry Operative builders
Sub-IndustryHomebuilding
SectorConstruction
CUSIP55267610
Phone303-773-1100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.29 billion
Cash Flow$4.24 per share
Book Value$28.49 per share

Profitability

Net Income$238.31 million

Miscellaneous

Employees1,656
Market Cap$2.17 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

M.D.C. (NYSE:MDC) Frequently Asked Questions

How has M.D.C.'s stock been impacted by COVID-19 (Coronavirus)?

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MDC stock has increased by 1.5% and is now trading at $34.48. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of M.D.C.?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 4 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for M.D.C..

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for M.D.C..

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) announced its quarterly earnings data on Tuesday, May, 5th. The construction company reported $0.56 EPS for the quarter, missing analysts' consensus estimates of $0.69 by $0.13. The construction company had revenue of $697.10 million for the quarter, compared to analyst estimates of $733.88 million. M.D.C. had a net margin of 7.01% and a return on equity of 13.48%. The business's quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the business earned $0.64 earnings per share. View M.D.C.'s earnings history.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. declared a quarterly dividend on Friday, April 3rd. Shareholders of record on Wednesday, May 6th will be paid a dividend of $0.33 per share on Wednesday, May 20th. This represents a $1.32 dividend on an annualized basis and a yield of 3.83%. The ex-dividend date is Tuesday, May 5th. View M.D.C.'s dividend history.

What price target have analysts set for MDC?

7 brokers have issued 12 month target prices for M.D.C.'s shares. Their forecasts range from $22.00 to $42.00. On average, they expect M.D.C.'s stock price to reach $32.00 in the next year. This suggests that the stock has a possible downside of 7.2%. View analysts' price targets for M.D.C..

Has M.D.C. been receiving favorable news coverage?

Media stories about MDC stock have been trending positive on Tuesday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. M.D.C. earned a news sentiment score of 2.6 on InfoTrie's scale. They also gave news headlines about the construction company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutM.D.C..

Are investors shorting M.D.C.?

M.D.C. saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,080,000 shares, a decline of 21.7% from the April 30th total of 1,380,000 shares. Based on an average daily volume of 724,800 shares, the short-interest ratio is currently 1.5 days. Currently, 2.2% of the shares of the stock are sold short. View M.D.C.'s Current Options Chain.

Who are some of M.D.C.'s key competitors?

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Verizon Communications (VZ), NVIDIA (NVDA), Intel (INTC), CVS Health (CVS), Walt Disney (DIS), AT&T (T) and Procter & Gamble (PG).

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the following people:
  • Mr. Larry A. Mizel, Chairman & CEO (Age 76)
  • Mr. David D. Mandarich, Pres, COO & Director (Age 71)
  • Mr. Robert Nathaniel Martin, Sr. VP, CFO & Principal Accounting Officer (Age 40)
  • Mr. Michael Touff, Sr. VP & Gen. Counsel (Age 74)
  • Mr. Kelly Taga, Chief Information Officer & VP

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (14.55%), State Street Corp (3.01%), Bank of New York Mellon Corp (2.13%), Vaughan Nelson Investment Management L.P. (1.35%), Geode Capital Management LLC (1.20%) and Advisory Research Inc. (0.70%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View institutional ownership trends for M.D.C..

Which major investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Morgan Stanley, Morgan Stanley, WINTON GROUP Ltd, William Blair Investment Management LLC, Schroder Investment Management Group, New York State Common Retirement Fund, and Invesco Ltd.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, and Raymond T Baker. View insider buying and selling activity for M.D.C..

Which major investors are buying M.D.C. stock?

MDC stock was bought by a variety of institutional investors in the last quarter, including Advisory Research Inc., Grantham Mayo Van Otterloo & Co. LLC, Bahl & Gaynor Inc., Natixis Advisors L.P., Acadian Asset Management LLC, State Street Corp, BlackRock Inc., and Comerica Bank. View insider buying and selling activity for M.D.C..

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $34.48.

How big of a company is M.D.C.?

M.D.C. has a market capitalization of $2.17 billion and generates $3.29 billion in revenue each year. The construction company earns $238.31 million in net income (profit) each year or $3.72 on an earnings per share basis. M.D.C. employs 1,656 workers across the globe.

What is M.D.C.'s official website?

The official website for M.D.C. is www.mdcholdings.com.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.